Loading insider details...
Latest Form 4 (Nov 18, 2026): Purchase of 3,751 CGON shares, $299.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 18, 2026 | CG Oncology, Inc. (CGON) | Purchase | 3,751 | $299.2K |
| Oct 19, 2026 | CG Oncology, Inc. (CGON) | Grant/Award | 92,000 | n/a |
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 1,669 | $141.9K |
| Feb 25, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 34,000 | n/a |
| Jan 7, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 2,500 | $101.5K |
| Jan 13, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 100,000 | n/a |
| Feb 12, 2024 | ImmunoGen, Inc. (IMGN) | Disposition to Issuer | 284,250 | n/a |
| Feb 5, 2024 | ImmunoGen, Inc. (IMGN) | Grant/Award | 19,458 | n/a |